Gastrointestinal absorption of drugs: methods and studies

Abstract— Physico‐chemical descriptors of drug molecules are often not adequate in predicting their oral bioavailability. In vitro methods can be useful in evaluating some of the different factors contributing to bioavailability. While physical parameters such as drug solubility may effect oral bioavailability, in most cases, the major determining factors are likely to be metabolism, and absorption at the intestinal level. Metabolism may be preabsorptive, as with peptides, or during absorption, particularly as a result of the activity of the intracellular enzyme CYP3A4. Absorption may be transcellular (membrane diffusion, carrier‐mediated, endocytosis) or paracellular, while p‐glycoprotein activity in the apical cell membrane may limit bioavailability by expelling drugs from the mucosal cells. Knowledge of the absorption mechanism is important in determining formulation strategies. The different in vitro techniques used to study absorption have advantages and disadvantages. Ussing chambers can be useful to measure bidirectional transport, but most studies use simple salt media, and full tissue viability is doubtful. Caco‐2 cell monolayers are human cells, but the system is static, and gives very low rates of transport, and exagerated enhancement of the paracellular route compared with small intestine. The rat everted gut sac incubated in tissue culture medium maintains tissue viability and gives reliable data, although it is a closed system. In situ perfusion gives no information on events at the cellular level, and absorption may be reduced by anaesthesia and surgical manipulation. In vivo perfusion in man, with multichannel tubes, gives valuable data, but is not practical for screening. Pharmacokinetic modelling can also give useful data such as the existence of different absorption sites. Permeability values from the literature show that for small hydrophilic molecules, which pass by the paracellular route, the improved everted sac gives values close to those for humans, while values with Caco‐2 cells are orders of magnitude lower.

[1]  G. Houin,et al.  The improved everted gut sac: a simple method to study intestinal P-glycoprotein , 1998 .

[2]  H. Junginger,et al.  Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[3]  A. Y. Lu,et al.  Role of pharmacokinetics and metabolism in drug discovery and development. , 1997, Pharmacological reviews.

[4]  P. Watkins,et al.  The barrier function of CYP3A4 and P-glycoprotein in the small bowel. , 1997, Advanced drug delivery reviews.

[5]  A. Yamamoto,et al.  Effects of various absorption enhancers on the intestinal absorption of water soluble drugs by in vitro Ussing chamber method: correlation with an in situ absorption experiment. , 1997, Biological & pharmaceutical bulletin.

[6]  H. Lennernäs,et al.  Regional Intestinal Permeability in Rats of Compounds with Different Physicochemical Properties and Transport Mechanisms , 1997, The Journal of pharmacy and pharmacology.

[7]  H Lennernäs,et al.  Human Jejunal Effective Permeability and Its Correlation with Preclinical Drug Absorption Models , 1997, The Journal of pharmacy and pharmacology.

[8]  P. Artursson,et al.  Diffusion of drugs in native and purified gastrointestinal mucus. , 1997, Journal of pharmaceutical sciences.

[9]  B. Hirst,et al.  Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption , 1997 .

[10]  D. Thakker,et al.  Applications of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium , 1997 .

[11]  W. Rubas,et al.  The effect of chemical modifications on octanol/water partition (log D) and permeabilities across Caco-2 monolayers , 1997 .

[12]  O. H. Chan,et al.  Discrimination between drug candidates using models for evaluation of intestinal absorption , 1997 .

[13]  Chao-pin Lee,et al.  Selection of development candidates based on in vitro permeability measurements , 1997 .

[14]  Ismael J. Hidalgo,et al.  Carrier-mediated transport and efflux mechanisms in Caco-2 cells , 1996 .

[15]  B. Levet-Trafit,et al.  Estimation of oral drug absorption in man based on intestine permeability in rats. , 1996, Life sciences.

[16]  Leslie Z. Benet,et al.  Intestinal drug metabolism and antitransport processes : A potential paradigm shift in oral drug delivery , 1996 .

[17]  P. Bhat,et al.  The limiting role of mucus in drug absorption : drug permeation through mucus solution , 1995 .

[18]  P. Artursson,et al.  Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers. , 1995, The Journal of pharmacology and experimental therapeutics.

[19]  Hans Lennernäs,et al.  EXPERIMENTAL ESTIMATION OF THE EFFECTIVE UNSTIRRED WATER LAYER THICKNESS IN THE HUMAN JEJUNUM, AND ITS IMPORTANCE IN ORAL-DRUG ABSORPTION , 1995 .

[20]  S. Lundin,et al.  Different properties of the paracellular pathway account for the regional small intestinal permeability to the peptide desmopressin. , 1995, Journal of pharmaceutical sciences.

[21]  P. Macheras,et al.  Biopharmaceutics Of Orally Administered Drugs , 1995 .

[22]  T. Kissel,et al.  Heterogeneity in the human intestinal cell line Caco-2 leads to differences in transepithelial transport , 1995 .

[23]  L. Benet,et al.  Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: Implications for drug delivery and activity in cancer chemotherapy , 1995, Molecular carcinogenesis.

[24]  R. Kimura,et al.  The effect of surgical bowel manipulation and anesthesia on intestinal glucose absorption in rats. , 1995, The Journal of clinical investigation.

[25]  P. Artursson,et al.  Co-cultures of human intestinal goblet (HT29-H) and absorptive (Caco-2) cells for studies of drug and peptide absorption , 1995 .

[26]  G. Houin,et al.  Estimation of the effective amount entering the body for drugs subject to enterohepatic recirculations. , 1995, Medical engineering & physics.

[27]  K. Hillgren,et al.  In vitro systems for studying intestinal drug absorption , 1995, Medicinal research reviews.

[28]  D. Scherman,et al.  Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers. , 1994, Biochemical pharmacology.

[29]  J. Kolars,et al.  CYP3A gene expression in human gut epithelium. , 1994, Pharmacogenetics.

[30]  J. Woodley,et al.  The potential use of tomato lectin for oral drug delivery: 2. Mechanism of uptake in vitro , 1994 .

[31]  G. Houin,et al.  Evidence for a second site of absorption of veralipride in the human small intestine. Use of a new drug delivery telemetric shuttle. , 1994, Arzneimittel-Forschung.

[32]  W. L. Chiou Determination of drug permeability in a flat or distended stirred intestine. Prediction of fraction dose absorbed in humans after oral administration. , 1994, International journal of clinical pharmacology and therapeutics.

[33]  G. Houin,et al.  Pharmacokinetic compartmental model with n sites of absorption along the gastrointestinal tract. , 1994, Arzneimittel-Forschung.

[34]  I. Hidalgo,et al.  Uptake and transepithelial transport of the orally absorbed cephalosporin cephalexin, in the human intestinal cell line, Caco-2 , 1994 .

[35]  J. Pató,et al.  Uptake and transport of poly(N-vinylpyrrolidone-co-maleic acid) by the adult rat small intestine cultured in vitro: Effect of chemical structure , 1994 .

[36]  U. Klotz,et al.  Extrahepatic Metabolism of Drugs in Humans , 1994, Clinical pharmacokinetics.

[37]  Y. Berger,et al.  Importance of the paracellular pathway for the transport of a new bisphosphonate using the human CACO-2 monolayers model. , 1993, Biochemical pharmacology.

[38]  K. D. Fine,et al.  Effect of D-glucose on intestinal permeability and its passive absorption in human small intestine in vivo. , 1993, Gastroenterology.

[39]  R. Conradi,et al.  Evidence for a polarized efflux system for peptides in the apical membrane of Caco-2 cells. , 1993, Biochemical and biophysical research communications.

[40]  P. Artursson,et al.  Epithelial transport of drugs in cell culture. VII: Effects of pharmaceutical surfactant excipients and bile acids on transepithelial permeability in monolayers of human intestinal epithelial (Caco-2) cells. , 1992, Journal of pharmaceutical sciences.

[41]  A. Sintov,et al.  Chondroitin sulfate: A potential biodegradable carrier for colon-specific drug delivery , 1992 .

[42]  H. Saito,et al.  Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: specific transport systems in apical and basolateral membranes. , 1992, The Journal of pharmacology and experimental therapeutics.

[43]  Hugh N. Nellans,et al.  B) Mechanisms of peptide and protein absorption , 1991 .

[44]  B. Hirst,et al.  Epithelial secretion of vinblastine by human intestinal adenocarcinoma cell (HCT-8 and T84) layers expressing P-glycoprotein. , 1991, British Journal of Cancer.

[45]  A. Rubinstein Microbially controlled drug delivery to the colon , 1990, Biopharmaceutics & drug disposition.

[46]  G. Amidon,et al.  Passive and carrier-mediated intestinal absorption components of captopril. , 1988, Journal of pharmaceutical sciences.

[47]  M. Takano,et al.  H+ coupled transport of p.o. cephalosporins via dipeptide carriers in rabbit intestinal brush-border membranes: difference of transport characteristics between cefixime and cephradine. , 1988, The Journal of pharmacology and experimental therapeutics.

[48]  P. Traber,et al.  Expression of cytochrome P450b and P450e genes in small intestinal mucosa of rats following treatment with phenobarbital, polyhalogenated biphenyls, and organochlorine pesticides. , 1988, The Journal of biological chemistry.

[49]  M C Willingham,et al.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[50]  P. Watkins,et al.  Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man. , 1987, The Journal of clinical investigation.

[51]  M. L. Gardner,et al.  A comparison of the structural integrity of several commonly used preparations of rat small intestine in vitro. , 1987, Clinical science.

[52]  R. Rowland,et al.  Uptake of free and liposome-entrapped125I-labelled PVP by rat intestinal sacs in vitro: evidence for endocytosis , 1981, Bioscience reports.

[53]  J. Woodley,et al.  Uptake of free and liposome-entrapped insulin by rat intestinal sacs in vitro , 1981, Bioscience reports.

[54]  R. Rowland,et al.  Uptake of free and liposome‐entrapped horseradish peroxidase by rat intestinal sacs in vitro , 1981, FEBS letters.

[55]  J. Woodley,et al.  The uptake of liposome-entrapped 125I-labelled poly(vinylpyrrolidone) by rat jejunum in vitro. , 1978, Biochimica et biophysica acta.

[56]  K. Isselbacher,et al.  MACROMOLECULAR ABSORPTION , 1972, The Journal of cell biology.

[57]  P. Kornguth,et al.  Histological reevaluation of everted gut technique for studying intestinal absorption. , 1970, European journal of pharmacology.

[58]  T. H. Wilson,et al.  The use of sacs of everted small intestine for the study of the transference of substances from the mucosal to the serosal surface , 1954, The Journal of physiology.

[59]  H H USSING,et al.  Active transport of sodium as the source of electric current in the short-circuited isolated frog skin. , 1951, Acta physiologica Scandinavica.

[60]  X. Boulenc Intestinal cell models. Their use in evaluating the metabolism and absorption of xenobiotics , 1997 .

[61]  G. Russell-Jones Utilization of the natural mechanism for vitamin B12 uptake for the oral delivery of therapeutics , 1996 .

[62]  D. Thakker,et al.  USE OF CACO-2 CELLS AS AN IN VITRO INTESTINAL ABSORPTION AND METABOLISM MODEL , 1994 .

[63]  M. Gottesman,et al.  Is the multidrug transporter a flippase? , 1992, Trends in biochemical sciences.

[64]  A. Zweibaum Differentiation of Human Colon Cancer Cells , 1991 .

[65]  P. Gervasi,et al.  Profile of drug-metabolizing enzymes in human ileum and colon. , 1989, Pharmacology.

[66]  N. Di Lascio,et al.  Tissue distribution of drug-metabolizing enzymes in humans. , 1988, Xenobiotica; the fate of foreign compounds in biological systems.

[67]  R. Rowland,et al.  The uptake of distearoylphosphatidylcholine/cholesterol liposomes by rat intestinal sacs in vitro. , 1981, Biochimica et biophysica acta.